Latest filing published 25 Aug 2026 for BEONE MEDICINES LTD, €4.8M.
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Xiaobin Wu: trading record in brief
This profile gathers the share dealings of Xiaobin Wu in BeOne Medicines Ltd. We count 5 filings; the first trade dates from 8 June 2026 and the latest from 25 August 2026.
Not one of the filings records a straightforward purchase or sale on the market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
On 25 August 2026 came the latest disclosure, a transaction for €4.8M in BeOne Medicines Ltd. Most trades are made public on the day they happen. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Xiaobin Wu
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 15,000 shares@ US$371.98ADSSEC144:0001950047-26-008690
- 1,292 shares@ US$276.25920.0009% mcap100.0% of flowADSSEC144:0001950047-26-006413
- 1,357 shares@ US$266.76260.0009% mcap40.7% of flowADSSEC144:0001950047-26-006180
- 626 shares@ US$261.20170.0004% mcap18.4% of flowADSSEC144:0001950047-26-005952
- 1,484 shares@ US$269.36530.0010% mcap31.1% of flowADSSEC144:0001950047-26-005749
5 of 5 declarations